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甘肽（GSH）形成 Michael加成产物。NAC 或 GSH可逆转紫草素萘醌类似
物的细胞毒活性，其机制与 Michael加成有关，推测紫草萘醌类化合物细胞
毒活性产生机制可能与体内的半胱氨酸残基形成 Michael 加成所致。MTT






























Shikonin derivatives, which have the basic structure of 1,4-naphthoquinone, 
can inhibited the growth of tumor cells included by HeLa or A549 cell lines. It is 
not clear 1,4-naphthoquinones the relationship betwe n the unit induce tumor 
cell death and form Michael adduct with nucleophilic thiol groups in intracellular 
biomolecules. To evaluate the cytotoxicity of shikonin derivatives, 
1,4-naphthoquinone analogues including shikonin, deoxyshikonin, juglone, 
1,4-naphthalene-diol, 1,4-naphthoquinone(NAP), and 5,8-dihydroxy-1,4-naph- 
thoquinone(DMNQ), were applied to investigate the features of cell growth 
inhibition, the structure-activity relationship and the mechanism of the 
cytoxicities of 1,4-naphthoquinone in human lung cancer A549 cells. The results 
indicated that 1,4-naphthoquinone analogues inhibited the growth of A549 cells 
and formed Michael adduct with a thiol nucleophile such as N-acetylcystine 
(NAC) or glutathione (GSH), and preincubation of NAC/GSH with 
naphthoquinone derivatives eliminated the cytotoxicity of shikonin analogues in 
cultured cells. These results suggested that the cystein residues in vivo contribute 
to the cytotoxicity of naphthoquinone derivatives and Michael adduct formation 
was responsible for the severe the 1,4-naphthoquinone cytotoxicity. Western blot 
analysis showed that the toxicity of these compounds decreased in the series of 
shikonin～ DMNQ > NAP, suggesting that side chain of shikonin，the hydroxyl 
of the side chain, and the double hydroxy substitute in naphthoquinone were 
responsible for the naphthoquinone’s cytotoxicity. The mechanisms of 
1,4-naphthoquinone analogues-induced tumor cell death involved in 
mitochondria pathway and the endoplasmic reticulum stress in A549 cells. 
In addition, a high-performance liquid chromatography electrospray 
















developed and validated for shikonin and isovalerylshikonin in rat plasma using 
emodin as internal standard (IS). The analytes were extracted from rat plasma 
with acetoacetate after 10% HCl treatment, methanol pr tein precipitation. The 
compounds were separated on a UltimateTM XB-C18 analytical column using a 
mobile phase of methanol / 10 mM ammonium acetate in water / acetonitrile 
containing 0.05% formic acid ( 45:10:45, v/v/v) with isogradient elution. All of 
the analytes were detected in negative ion mode using multiple reaction 
monitoring (MRM). LLOQs were 0.5 ng/mL for shikonin, and 9 ng/mL for 
isovalerylshikonin, respectively. Correlation coefficient (r) values for the linear 
range of the analytes were greater than 0.99. The intra-day and inter-day 
precision and accuracy were better than 13.19%. The relative and absolute 
recovery was above 74% and no matrix effects were obs rved for all the analytes. 
This validated method provides a simple, rapid and robust procedure for the 
pharmacokinetic studies of the shikonin analogues in rats (n = 4). 















符号                         英文含义                   中文含义 
PBS                   Phosphate-buffered saline     磷酸盐缓冲液 
MTT              thiazolyl blue tetrazolium bromide     四甲基偶氮唑盐 
DMSO                   Dimethyl Sulfoxide                二甲亚砜 
OD                       optical density                    光密度 
IC50               half-maximal inhibitory concentration   半数致死量
NAC                    N-acetyl-L-cysteine        N-乙酰-L-半胱氨酸 
GSH                 Glutathinone S-transferase          谷胱甘肽 
PMSF              Phenylmethanesulfonyl fluoride        苯甲基磺酰氟 
SDS                    Sodium dodecyl sulfate        十二烷基磺酸钠 
BcL-2               B cell lymphoma/ leukemia 2 
Bax                 BcL-2 associated X protein 
P-JNK            phosphate c-Jun N-terminal Kinase       磷酸化 JNK 
JNK                    c-Jun N-terminal Kinase     氨基末端激酶 
CYC                       Cytochrome C               细胞色素 C 
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